The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Pleiotrophin signals increased tyrosine phosphorylation of β-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase β/ζ
Open accessAbstract
Pleiotrophin (PTN) is a platelet-derived growth factor-inducible, 18-kDa heparin-binding cytokine that signals diverse phenotypes in normal and deregulated cellular growth and differentiation. To seek the mechanisms of PTN signaling, we studied the interactions of PTN with the receptor protein tyrosine phosphatase (RPTP) β/ζ in U373-MG cells. Our results suggest that PTN is a natural ligand for RPTP β/ζ. PTN signals through “ligand-dependent receptor inactivation” of RPTP β/ζ and disrupts its normal roles in the regulation of steady-state tyrosine phosphorylation of downstream signaling molecules. We have found that PTN binds to and functionally inactivates the catalytic activity of RPTP β/ζ. We also have found that an active site-containing domain of RPTP β/ζ both binds β-catenin and functionally reduces its levels of tyrosine phosphorylation when added to lysates of pervanidate-treated cells. In contrast, an (inactivating) active-site mutant of RPTP β/ζ also binds β-catenin but fails to reduce tyrosine phosphorylation of β-catenin. Finally, in parallel to its ability to inactivate endogenous RPTP β/ζ, PTN sharply increases tyrosine phosphorylation of β-catenin in PTN-treated cells. The results suggest that in unstimulated cells, RPTP β/ζ is intrinsically active and functions as an important regulator in the reciprocal control of the steady-state tyrosine phosphorylation levels of β-catenin by tyrosine kinases and phosphatases. The results also suggest that RPTP β/ζ is a functional receptor for PTN; PTN signals through ligand-dependent receptor inactivation of RPTP β/ζ to increase levels of tyrosine phosphorylation of β-catenin to initiate downstream signaling. PTN is the first natural ligand identified for any of the RPTP family; its identification provides a unique tool to pursue the novel signaling pathway activated by PTN and the relationship of PTN signaling with other pathways regulating β-catenin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Growth factor signaling by receptor tyrosine kinases
Schlessinger, J., & Ullrich, A. (1992) · Neuron · doi:10.1016/0896-6273(92)90177-f · Cited by 1,430
Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422
Protein Tyrosine Phosphatases: A Diverse Family of Intracellular and Transmembrane Enzymes
Fischer, E. H., Charbonneau, H., & Tonks, N. K. (1991) · Science · doi:10.1126/science.1650499 · Cited by 956
Hoschuetzky, H., Aberle, H., & Kemler, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.5.1375 · Cited by 711
Signal transduction through beta-catenin and specification of cell fate during embryogenesis.
Miller, J. R., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.20.2527 · Cited by 656
Hunter, T. (1997) · Cell · doi:10.1016/s0092-8674(00)81872-3 · Cited by 550
From Form to Function: Signaling by Protein Tyrosine Phosphatases
Tonks, N. K., & Neel, B. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81357-4 · Cited by 531
Li, Y.-S., Milner, P. G., Chauhan, A. K., Watson, M. A., Hoffman, R. M., Kodner, C. M., Milbrandt, J., & Deuel, T. F. (1990) · Science · doi:10.1126/science.2270483 · Cited by 474
Self-citationPeles, E., Nativ, M., Campbell, P. L., Sakurai, T., Martinez, R., Levt, S., Clary, D. O., Schilling, J., Barnea, G., Plowman, G. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90312-7 · Cited by 397
Cited by
Protein tyrosine phosphatases: from genes, to function, to disease
Tonks, N. K. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2039 · Cited by 1,677
Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate
Sugahara, K., Mikami, T., Uyama, T., Mizuguchi, S., Nomura, K., & Kitagawa, H. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.09.011 · Cited by 694
Protein-tyrosine phosphatases and cancer
Östman, A., Hellberg, C., & Böhmer, F. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1837 · Cited by 657
Combinatorial control of the specificity of protein tyrosine phosphatases
Tonks, N. K., & Neel, B. G. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00196-4 · Cited by 501
Lilien, J., & Balsamo, J. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.009 · Cited by 465
Tonks, N. K. (2013) · The FEBS Journal · doi:10.1111/febs.12077 · Cited by 432
Anaplastic lymphoma kinase: signalling in development and disease
Palmer, R. H., Vernersson, E., Grabbe, C., & Hallberg, B. (2009) · Biochemical Journal · doi:10.1042/bj20090387 · Cited by 423
Inhibitors of Protein Tyrosine Phosphatases: Next‐Generation Drugs?
Bialy, L., & Waldmann, H. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461517 · Cited by 420
Muramatsu, T. (2002) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003231 · Cited by 405
Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases
Östman, A. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01990-0 · Cited by 383
Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment
Hoelzinger, D. B., Demuth, T., & Berens, M. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm187 · Cited by 372
Midkine and pleiotrophin in neural development and cancer
Kadomatsu, K., & Muramatsu, T. (2004) · Cancer Letters · doi:10.1016/s0304-3835(03)00450-6 · Cited by 354
Shi, Y., Ping, Y.-F., Zhou, W., He, Z.-C., Chen, C., Bian, B.-S.-J., Zhang, L., Chen, L., Lan, X., Zhang, X.-C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15080 · Cited by 344
Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target
Filippou, P. S., Karagiannis, G. S., & Constantinidou, A. (2020) · Oncogene · doi:10.1038/s41388-019-1124-8 · Cited by 331
Nawroth, R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf497 · Cited by 313
Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells
Himburg, H. A., Muramoto, G. G., Daher, P., Meadows, S. K., Russell, J. L., Doan, P., Chi, J.-T., Salter, A. B., Lento, W. E., Reya, T., et al. (2010) · Nature Medicine · doi:10.1038/nm.2119 · Cited by 284
Identification of molecular subtypes of glioblastoma by gene expression profiling
Mischel, P. S., Shai, R., Shi, T., Horvath, S., Lu, K. V., Choe, G., Seligson, D., Kremen, T. J., Palotie, A., Liau, L. M., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206344 · Cited by 272
Bilsland, J. G., Wheeldon, A., Mead, A., Znamenskiy, P., Almond, S., Waters, K. A., Thakur, M., Beaumont, V., Bonnert, T. P., Heavens, R., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301446 · Cited by 188
Notaras, M., Lodhi, A., Dündar, F., Collier, P., Sayles, N. M., Tilgner, H., Greening, D., & Colak, D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01316-6 · Cited by 150
A review of the evidence for the canonical Wnt pathway in autism spectrum disorders
Kalkman, H. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-10 · Cited by 142
Pleiotrophin: Activity and mechanism
(2020) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2020.02.003 · Cited by 98
Herradón, G., & Pérez‐García, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12312 · Cited by 88
Skillbäck, T., Mattsson, N., Hansson, K., Mirgorodskaya, E., Dahlén, R., van der Flier, W., Scheltens, P., Duits, F., Hansson, O., Teunissen, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13831-0 · Cited by 61
Chondroitin sulfate proteoglycans in neural development and plasticity
Maeda, N. (2010) · Frontiers in Bioscience · doi:10.2741/3637 · Cited by 44
Michelotti, G. A., Tucker, A., Swiderska-Syn, M., Machado, M. V., Choi, S. S., Kruger, L., Soderblom, E., Thompson, J. W., Mayer-Salman, M., Himburg, H. A., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308176 · Cited by 40
Shang, D., Xu, X., Wang, D., Li, Y., & Liu, Y. (2013) · World Journal of Urology · doi:10.1007/s00345-013-1077-4 · Cited by 12
Yadav, C. J., Yadav, U., Afrin, S., Lee, J.-Y., Kamel, J., & Park, K.-M. (2026) · Biomaterials Science · doi:10.1039/d5bm01589h · Cited by 2
Metadata
- Authors
- Meng, K., Rodríguez-Peña, A., Dimitrov, T., Chen, W., Yamin, M., Noda, M., & Deuel, T. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-03-07
- Volume
- 97
- Issue
- 6
- Pages
- 2603-2608
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1969832217
- Cited by
- 418
- References
- 46
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.